Steigerwald Gordon & Koch’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.4M Sell
70,256
-626
-0.9% -$214K 2.52% 16
2026
Q1
$24.9M Buy
70,882
+310
+0.4% +$111K 2.56% 14
2025
Q4
$23.1M Sell
70,572
-760
-1% -$241K 2.22% 18
2025
Q3
$20.1M Buy
71,332
+479
+0.7% +$139K 1.93% 21
2025
Q2
$19.8M Buy
70,853
+766
+1% +$217K 2.09% 19
2025
Q1
$21.8M Sell
70,087
-363
-0.5% -$107K 2.44% 17
2024
Q4
$18.4M Buy
70,450
+434
+0.6% +$129K 2.07% 20
2024
Q3
$22.6M Buy
70,016
+1,473
+2% +$482K 2.46% 16
2024
Q2
$21.4M Buy
68,543
+1,253
+2% +$368K 2.59% 9
2024
Q1
$19.1M Buy
67,290
+934
+1% +$273K 2.38% 14
2023
Q4
$19.1M Buy
66,356
+909
+1% +$248K 2.59% 12
2023
Q3
$17.6M Buy
65,447
+1,371
+2% +$342K 2.68% 12
2023
Q2
$14.2M Buy
64,076
+1,551
+2% +$360K 2.09% 20
2023
Q1
$15.1M Buy
62,525
+1,633
+3% +$401K 2.26% 18
2022
Q4
$16M Buy
60,892
+997
+2% +$267K 2.54% 13
2022
Q3
$13.5M Buy
59,895
+1,185
+2% +$287K 2.47% 12
2022
Q2
$14.3M Buy
58,710
+368
+0.6% +$90.2K 2.49% 14
2022
Q1
$14.1M Buy
58,342
+803
+1% +$184K 2.15% 18
2021
Q4
$12.9M Buy
57,539
+1,795
+3% +$379K 1.95% 22
2021
Q3
$11.9M Buy
55,744
+290
+0.5% +$66.7K 1.94% 26
2021
Q2
$13.5M Buy
55,454
+1,427
+3% +$351K 2.24% 18
2021
Q1
$13.4M Sell
54,027
-170
-0.3% -$40.6K 2.5% 15
2020
Q4
$12.5M Buy
54,197
+765
+1% +$176K 2.53% 15
2020
Q3
$13.6M Buy
53,432
+153
+0.3% +$37.9K 3.21% 7
2020
Q2
$12.6M Buy
53,279
+489
+0.9% +$112K 3.33% 5
2020
Q1
$10.7M Sell
52,790
-2,401
-4% -$524K 3.63% 5
2019
Q4
$13.3M Sell
55,191
-325
-0.6% -$71.6K 3.13% 6
2019
Q3
$10.7M Buy
55,516
+77
+0.1% +$14.8K 2.74% 14
2019
Q2
$10.2M Sell
55,439
-41
-0.1% -$7.34K 2.64% 18
2019
Q1
$10.5M Sell
55,480
-753
-1% -$144K 2.78% 15
2018
Q4
$10.9M Buy
56,233
+192
+0.3% +$37.5K 3.26% 4
2018
Q3
$11.6M Sell
56,041
-1,623
-3% -$320K 2.92% 11
2018
Q2
$10.6M Buy
57,664
+979
+2% +$173K 2.82% 15
2018
Q1
$9.66M Sell
56,685
-1,386
-2% -$254K 2.7% 18
2017
Q4
$10.1M Sell
58,071
-3,203
-5% -$567K 2.77% 16
2017
Q3
$11.4M Buy
61,274
+213
+0.3% +$37.7K 3.14% 4
2017
Q2
$10.4M Buy
61,061
+1,927
+3% +$313K 2.94% 9
2017
Q1
$9.62M Buy
59,134
+2,550
+5% +$424K 2.85% 9
2016
Q4
$8.18M Buy
56,584
+2,785
+5% +$419K 2.61% 22
2016
Q3
$8.86M Buy
53,799
+627
+1% +$106K 3.08% 6
2016
Q2
$7.97M Buy
53,172
+2,739
+5% +$426K 2.85% 10
2016
Q1
$7.42M Buy
50,433
+568
+1% +$84.4K 2.83% 16
2015
Q4
$7.94M Sell
49,865
-147
-0.3% -$23.1K 3.24% 3
2015
Q3
$6.78M Buy
50,012
+1,597
+3% +$252K 3% 11
2015
Q2
$7.28M Buy
48,415
+587
+1% +$94K 3.32% 5
2015
Q1
$7.49M Buy
47,828
+485
+1% +$76.4K 3.48% 4
2014
Q4
$7.41M Sell
47,343
-3,238
-6% -$505K 3.71% 3
2014
Q3
$6.99M Sell
50,581
-1,733
-3% -$226K 3.67% 4
2014
Q2
$6.09M Buy
52,314
+2,406
+5% +$279K 3.25% 10
2014
Q1
$6.11M Buy
49,908
+2,973
+6% +$361K 3.5% 5
2013
Q4
$5.31M Buy
46,935
+5,214
+12% +$593K 3.17% 12
2013
Q3
$4.63M Buy
41,721
+623
+2% +$67.6K 3.02% 15
2013
Q2
$4.02M Buy
+41,098
New +$4.26M 2.84% 17

Other funds holding AMGN

Steigerwald Gordon & Koch's AMGN Position: Q2 2026 in Review

Steigerwald Gordon & Koch reduced its Amgen (AMGN) stake by 0.88% in Q2 2026, selling an estimated $214K and leaving 70,256 shares worth $25.4M. The position accounts for 2.52% of the portfolio, ranked #16.

Steigerwald Gordon & Koch first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,255 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Steigerwald Gordon & Koch held 70,256 shares of Amgen worth $25.4M as of Q2 2026.
  • Steigerwald Gordon & Koch sold 626 Amgen shares in Q2 2026, an estimated $214K.
  • Amgen made up 2.52% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #16 holding.
  • Steigerwald Gordon & Koch first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 1,255 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.